CD44 and colorectal carcinoma: In CRC-specific applications, common receptors targeted include EpCAM (via aptamers), CD44 (via hyaluronic acid), CEA (via scFv antibody fragments), P-selectin (via fucoidan), folate receptors (via folic acid), and ASGPR (via galactose).